Principal Financial Group
BVS icon

Principal Financial Group’s Bioventus BVS Stock Holding History

Principal Financial Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-81,371
Closed -$605K – 2196
2025
Q4 		$605K Buy
81,371
+25,745
+46% +$185K ﹤0.01% 2032
2025
Q3 		$372K Buy
55,626
+30,305
+120% +$210K ﹤0.01% 2101
2025
Q2 		$168K Buy
25,321
+5,666
+29% +$40.2K ﹤0.01% 2142
2025
Q1 		$180K Buy
19,655
+427
+2% +$4.26K ﹤0.01% 2066
2024
Q4 		$202K Buy
19,228
+1,652
+9% +$19.5K ﹤0.01% 2103
2024
Q3 		$210K Buy
+17,576
New +$152K ﹤0.01% 2093
2022
Q3 		– Sell
-10,995
Closed -$75K – 2503
2022
Q2 		$75K Buy
+10,995
New +$112K ﹤0.01% 2429

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Principal Financial Group's BVS Position: Q1 2026 in Review

Principal Financial Group sold out of Bioventus (BVS) in Q1 2026, closing a stake of 81,371 shares — an estimated $605K sold.

Principal Financial Group first reported a position in BVS in Q2 2022 and held it in 7 quarters. The position peaked at $605K in Q4 2025. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Principal Financial Group reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • Principal Financial Group sold 81,371 Bioventus shares in Q1 2026, an estimated $605K.
  • Principal Financial Group first reported a position in Bioventus in Q2 2022 and held it in 7 quarters.
  • Principal Financial Group's Bioventus position peaked at $605K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.